Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.1093/ajhp/zxab050

http://scihub22266oqcxt.onion/10.1093/ajhp/zxab050
suck pdf from google scholar
33599751!7929424!33599751
unlimited free pdf from europmc33599751    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi

pmid33599751      Am+J+Health+Syst+Pharm 2021 ; 78 (9): 800-805
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Cleveland Clinic International IV Robotics Summit #MMPMID33599751
  • Long J; Calabrese S; Al-Jedai A; Boyd A; Cotugno M; Dorn M; Fanikos J; Freudiger MJ; Kraemer I; Lopez-Cabezas C; Smith A; de Stoppelaar FM; Usher J; Yaniv AW; Knoer S
  • Am J Health Syst Pharm 2021[Apr]; 78 (9): 800-805 PMID33599751show ga
  • PURPOSE: The proceedings of an international summit on the current and desired future state of use of robotic systems to compound intravenous (IV) solutions are summarized. SUMMARY: The International IV Robotics Summit was held at the Cleveland Clinic main campus in Cleveland, OH, on April 29 and 30, 2019. The purpose of the summit was 2-fold: (1) to define the current state of robotic IV compounding and (2) to develop a guide for automation companies, pharmacy departments, and drug manufacturers to improve the technology and expand the use of IV robotics in health systems in the future. The first day of the summit included 45-minute presentations by each of the speakers. Each lecturer recounted a different hospital's experience implementing and using IV robotics. On day 2 of the summit, an expert panel dedicated to mapping the future of IV robotics was convened to determine barriers to widespread adoption of IV robotics in health systems and offer potential solutions to remove these barriers. The expert panel targeted 3 specific audiences: robot manufacturers, drug manufacturers, and fellow pharmacy leaders. CONCLUSION: It is the hope of the international faculty that the information that emerged from the summit can be used by others to successfully implement IV compounding robotics in their sterile products areas to maximize patient safety. The summit also served as a call to action for pharmacy leaders, drug manufacturers, and robotic companies to develop a safer, more efficient future for patients by working together to optimize the development and operation of IV robotics.
  • |*Robotics[MESH]
  • |Automation[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box